Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: HBV-Induced Hepatocellular Carcinoma: Molecular and Clinical Aspects

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 30 Oct 2020

Guest Editor(s)

  • Antonio Bertoletti, MD
    Division Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore City, Singapore.

    Website | E-mail

Special Issue Introduction

This special issue discusses the following topics:

1. Some epigenetic aspect of HBV-HCC.
2. Occult Hepatitis B Virus Infection and Liver Cancer: Molecular Mechanisms
3. HCC in sub-Saharan Africa
4. Prevention of HBV-HCC
5. HBV-DNA integration and HCC
6. The effects of HBV-DNA integrated into genomes of hepatocellular carcinoma
7. HBV genetic variability to the onset of Hepatocellular Carcinoma
8. Optimizing the secondary prevention of hepatocellular carcinoma in patients with chronic Hepatitis B: lessen from real-world evidence
9. Initial Hepadnavirus-Hepatocyte Genomic Integration: Sites, Mechanism of Formation and Significance in Carcinogenesis
10. Tumor microenvironment in HBV related HCC
11. Role of misfolded NCoR mediated transcriptional deregulation in the pathogenesis of HCC
12. Mechanism of HBV-mediated hepatocarcinogenesis with emphasis on epigenetics


1. Ernesto Guccione Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
2. Giovanni Raimondo & Teresa Pollicino Division of Clinical and Molecular Hepatology, University of Messina, Messina, Italy.
3. Anna Kramvis Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.
4. Jiahorng Kao Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
5. Dake Zhang & Changqing Zeng Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
6. Ming Kuang Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
7. Valentina Svicher & Romina Salpini Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
8. Jonggi Choi Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, South Korea.
9. Rino Gani Hepatobiliary Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
10. Thomas I. Michalak Molecular Virology and Hepatology Research Group, Division of BioMedical Sciences, Faculty of Medicine, Health Sciences Centre, Memorial University, Newfoundland, Canada.
11. Osamu Yoshida Department of Gastroenterology and Metabology, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan.
12. Matiullah Khan Institute of Medicine, Science & Technology, Bedong, Malaysia.
13. David Handojo Muljono Hepatitis Department, Medicine Hepatitis Department, Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
14. Ourania Andrisani Department of Basic Medical Sciences and Purdue Center for Cancer Research, Purdue University, West Lafayette, USA.
The list is arranged in no particular order and to be updated.

Submission Deadline

30 Oct 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 30 Oct 2020
Contacts: Haidi Ding, Assistant Editor,

Published Articles

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties